Integra Lifesciences Holdings Stock Price on October 31, 2024
| IART Stock | USD 24.24 0.66 2.80% |
Below is the normalized historical share price chart for Integra LifeSciences Holdings extending back to August 16, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Integra LifeSciences stands at 24.24, as last reported on the 26th of November, with the highest price reaching 24.43 and the lowest price hitting 23.77 during the day.
If you're considering investing in Integra Stock, it is important to understand the factors that can impact its price. Integra LifeSciences appears to be not too volatile, given 3 months investment horizon. Integra LifeSciences holds Efficiency (Sharpe) Ratio of 0.0868, which attests that the entity had a 0.0868% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Integra LifeSciences, which you can use to evaluate the volatility of the firm. Please utilize Integra LifeSciences' Risk Adjusted Performance of 0.0646, market risk adjusted performance of 0.2764, and Downside Deviation of 2.54 to validate if our risk estimates are consistent with your expectations.
At this time, Integra LifeSciences' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 4 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 528.7 K in 2024. . At this time, Integra LifeSciences' Price Fair Value is comparatively stable compared to the past year. Integra Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of August 1995 | 200 Day MA 27.3605 | 50 Day MA 20.08 | Beta 1.084 |
Integra |
Sharpe Ratio = 0.0868
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IART | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.05 actual daily | 36 64% of assets are more volatile |
Expected Return
| 0.35 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Integra LifeSciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integra LifeSciences by adding it to a well-diversified portfolio.
Price Book 1.1958 | Enterprise Value Ebitda 18.807 | Price Sales 1.1627 | Shares Float 66 M | Wall Street Target Price 28.1111 |
Related Headline
Merit Medical Headline on 31st of October 2024
Merit Medical benefits from revenue growth in both segments and all its product categories within its Cardiovascular unit in the third quarter.
Integra LifeSciences Valuation on October 31, 2024
It is possible to determine the worth of Integra LifeSciences on a given historical date. On October 31, 2024 Integra was worth 19.54 at the beginning of the trading date compared to the closed value of 18.76. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Integra LifeSciences stock. Still, in general, we apply an absolute valuation method to find Integra LifeSciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integra LifeSciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Integra LifeSciences' related companies.
| Open | High | Low | Close | Volume | |
| 19.35 | 19.87 | 19.23 | 19.48 | 425,978 | |
10/31/2024 | 19.54 | 19.54 | 18.48 | 18.76 | 1,137,281 |
| 18.98 | 19.71 | 18.98 | 19.28 | 2,158,353 |
| Backtest Integra LifeSciences | | | Integra LifeSciences History | | | Integra LifeSciences Valuation | Previous | Next |
Integra LifeSciences Trading Date Momentum on October 31, 2024
| On November 01 2024 Integra LifeSciences Holdings was traded for 19.28 at the closing time. The top price for the day was 19.71 and the lowest listed price was 18.98 . The trading volume for the day was 2.2 M. The trading history from November 1, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 2.77% . The trading delta at closing time against the current closing price is 34.01% . |
Integra LifeSciences Fundamentals Correlations and Trends
By evaluating Integra LifeSciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Integra LifeSciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Integra financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Integra LifeSciences Stock history
Integra LifeSciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Integra is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Integra LifeSciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Integra LifeSciences stock prices may prove useful in developing a viable investing in Integra LifeSciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 80.3 M | 67.2 M | |
| Net Income Applicable To Common Shares | 207.6 M | 218 M |
Integra LifeSciences Quarterly Net Working Capital |
|
Integra LifeSciences Stock Technical Analysis
Integra LifeSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Integra LifeSciences Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Integra LifeSciences Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Integra LifeSciences November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Integra LifeSciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Integra LifeSciences shares will generate the highest return on investment. By undertsting and applying Integra LifeSciences stock market strength indicators, traders can identify Integra LifeSciences Holdings entry and exit signals to maximize returns
Integra LifeSciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Integra LifeSciences' price direction in advance. Along with the technical and fundamental analysis of Integra Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Integra to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0646 | |||
| Jensen Alpha | 0.155 | |||
| Total Risk Alpha | (0.34) | |||
| Sortino Ratio | 0.0641 | |||
| Treynor Ratio | 0.2664 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.